NRIX compared with IMTX: revenue, margins and what each company keeps, and the suppliers and customers both name

NRIXNurix Therapeutics, Inc.

Mkt capRevenueRevenue

IMTXImmatics N.V.

Mkt capRevenueRevenue

Compare

NRIXNurix Therapeutics, Inc.

IMTXImmatics N.V.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

NRIX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±17.9%▼−0.14%×0.01

Q2 FY26±16.5%▼−6.60%×0.40

Apr 8 '26±25.7%▼−4.59%×0.18

Q1 FY26±17.3%▼−1.57%×0.09

IMTX

No earnings history for IMTX.

= impliedNRIX realized, solidIMTX realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedSource: market data

NRIXNurix Therapeutics, Inc.

25.82▲+0.46%· post 17.50

Mkt cap$2.8BRevenue$673MQ3 FY26Revenue$84MFY25

IMTXImmatics N.V.

7.05▼−0.09%· post 7.07

ClosedNov 3 '26

Mkt cap$946.5MRevenue—Revenue—

Compare

ClosedNov 3 '26

NRIXNurix Therapeutics, Inc.

IMTXImmatics N.V.

25.82▲+0.46%post 17.50

Price

7.05▼−0.09%post 7.07

$2.8B

Mkt cap

$946.5M

Q3 FY26$673M

Revenue

—

FY25$84M

Revenue

—

NRIX25.82▲+0.46%vsIMTX7.05▼−0.09%ClosedNov 3 '26